Skip to main content
. 2021 Oct 25;160:261–272. doi: 10.1016/j.ejca.2021.10.009

Fig. 3.

Fig. 3

Multivariable analysis for the subgroup of patients with active malignancy and COVID-19. Multivariable analyses of a fatal outcome of COVID-19 in the group of patients considered having an active malignancy (n = 471).